Form 4: Monte Rosa Therapeutics Officer Sells Shares to Cover Tax Obligations

Edmund Dunn, Principal Accounting Officer of Monte Rosa Therapeutics, sold 1,207 shares of common stock on June 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On June 3, 2024, Edmund Dunn, the Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE), sold 1,207 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $4.0396, with individual transactions ranging from $4.0111 to $4.04.
• Following the transaction, Dunn still beneficially owns 15,554 shares of Monte Rosa Therapeutics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. An officer sold shares to cover taxes, which is a normal occurrence.

Industry Context

Form 4 filings are a routine part of the US stock market, and are required by the SEC to provide transparency when company insiders trade their company's stock. This filing indicates that the Principal Accounting Officer sold shares to cover tax obligations, which is a common practice.

Key Dates